Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

NCT00516269 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Breast Cancer
Fatigue
Gastrointestinal Cancer

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]